These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 32426902

  • 1. Preparation and evaluation of 99m Tc-HYNIC-D (TPPE) as a new targeted imaging probe for detection of colon cancer: Preclinical comparison with 99m Tc-HYNIC-EPPT.
    Maleki F, Masteri Farahani A, Sadeghzadeh N, Mardanshahi A, Abediankenari S.
    Chem Biol Drug Des; 2020 Nov; 96(5):1223-1231. PubMed ID: 32426902
    [Abstract] [Full Text] [Related]

  • 2. 99mTc labeled D(LPR): A novel retro-inverso peptide for VEGF receptor-1 targeted tumor imaging.
    Rezazadeh F, Sadeghzadeh N, Abedi SM, Abediankenari S.
    Nucl Med Biol; 2018 Nov; 62-63():54-62. PubMed ID: 29885559
    [Abstract] [Full Text] [Related]

  • 3. Formulation and Preclinical Testing of Tc-99m-Labeled HYNIC-Glc-FAPT as a FAP-Targeting Tumor Radiotracer.
    Yang X, Li G, Ruan C, Hu K, Tang G.
    Bioconjug Chem; 2023 Nov 15; 34(11):2133-2143. PubMed ID: 37874952
    [Abstract] [Full Text] [Related]

  • 4. An improved 99mTc-HYNIC-(Ser)3-LTVSPWY peptide with EDDA/tricine as co-ligands for targeting and imaging of HER2 overexpression tumor.
    Khodadust F, Ahmadpour S, Aligholikhamseh N, Abedi SM, Hosseinimehr SJ.
    Eur J Med Chem; 2018 Jan 20; 144():767-773. PubMed ID: 29291444
    [Abstract] [Full Text] [Related]

  • 5. 99mTc-labeled bombesin(7-14)NH2 with favorable properties for SPECT imaging of colon cancer.
    Shi J, Jia B, Liu Z, Yang Z, Yu Z, Chen K, Chen X, Liu S, Wang F.
    Bioconjug Chem; 2008 Jun 20; 19(6):1170-8. PubMed ID: 18491928
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression.
    Decristoforo C, Faintuch-Linkowski B, Rey A, von Guggenberg E, Rupprich M, Hernandez-Gonzales I, Rodrigo T, Haubner R.
    Nucl Med Biol; 2006 Nov 20; 33(8):945-52. PubMed ID: 17127166
    [Abstract] [Full Text] [Related]

  • 8. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
    Ortiz-Arzate Z, Santos-Cuevas CL, Ocampo-García BE, Ferro-Flores G, García-Becerra R, Estrada G, Gómez-Argumosa E, Izquierdo-Sánchez V.
    Nucl Med Commun; 2014 Apr 20; 35(4):423-32. PubMed ID: 24335877
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of a New 99mTc-labeled GnRH Analogue as a Possible Imaging Agent for Prostate Cancer Detection.
    Farahani AM, Maleki F, Sadeghzadeh N, Abediankenari S, Abedi SM, Erfani M.
    Anticancer Agents Med Chem; 2020 Apr 20; 20(14):1695-1703. PubMed ID: 32560611
    [Abstract] [Full Text] [Related]

  • 10. 99mTc-HYNIC-(tricine/EDDA)-FROP peptide for MCF-7 breast tumor targeting and imaging.
    Ahmadpour S, Noaparast Z, Abedi SM, Hosseinimehr SJ.
    J Biomed Sci; 2018 Feb 19; 25(1):17. PubMed ID: 29455647
    [Abstract] [Full Text] [Related]

  • 11. Tricine co-ligand improved the efficacy of 99mTc-HYNIC-(Ser)3-J18 peptide for targeting and imaging of non-small-cell lung cancer.
    Shaghaghi Z, Abedi SM, Hosseinimehr SJ.
    Biomed Pharmacother; 2018 Aug 19; 104():325-331. PubMed ID: 29775901
    [Abstract] [Full Text] [Related]

  • 12. Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies.
    Faintuch BL, Teodoro R, Duatti A, Muramoto E, Faintuch S, Smith CJ.
    Nucl Med Biol; 2008 May 19; 35(4):401-11. PubMed ID: 18482677
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of 99mTc-HYNIC-(ser)3-LTVPWY peptide for glioblastoma imaging.
    Shahsavari S, Shaghaghi Z, Abedi SM, Hosseinimehr SJ.
    Int J Radiat Biol; 2020 Apr 19; 96(4):502-509. PubMed ID: 31829777
    [Abstract] [Full Text] [Related]

  • 14. Synthesis, radiolabeling and evaluation of [99mTc][Tc-HYNIC/EDDA]-Met(O) as a early agent for amino acid metabolic imaging in C6 glioblastoma tumor.
    Dinmohammadi F, Erfani M, Shamsaei M, Shirmardi SP, Goudarzi M.
    Bioorg Chem; 2023 Jan 19; 130():106237. PubMed ID: 36402025
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of [99mTc/EDDA/HYNIC0]octreotide derivatives compared with [111In-DOTA0,Tyr3, Thr8]octreotide and [111In-DTPA0]octreotide: does tumor or pancreas uptake correlate with the rate of internalization?
    Storch D, Béhé M, Walter MA, Chen J, Powell P, Mikolajczak R, Mäcke HR.
    J Nucl Med; 2005 Sep 19; 46(9):1561-9. PubMed ID: 16157541
    [Abstract] [Full Text] [Related]

  • 16. Coligand effects on the solution stability, biodistribution and metabolism of the (99m)Tc-labeled cyclic RGDfK tetramer.
    Liu S, Kim YS, Hsieh WY, Gupta Sreerama S.
    Nucl Med Biol; 2008 Jan 19; 35(1):111-21. PubMed ID: 18158950
    [Abstract] [Full Text] [Related]

  • 17. 99m Tc-(EDDA/tricine)-HYNIC-GnRH analogue as a potential imaging probe for diagnosis of prostate cancer.
    Masteri Farahani A, Maleki F, Sadeghzadeh N, Abediankenari S, Abedi SM, Erfani M.
    Chem Biol Drug Des; 2020 Aug 19; 96(2):850-860. PubMed ID: 32279449
    [Abstract] [Full Text] [Related]

  • 18. Introduction of an 8-aminooctanoic acid linker enhances uptake of 99mTc-labeled lactam bridge-cyclized α-MSH peptide in melanoma.
    Guo H, Miao Y.
    J Nucl Med; 2014 Dec 19; 55(12):2057-63. PubMed ID: 25453052
    [Abstract] [Full Text] [Related]

  • 19. [Comparative study of the biodistribution of (99m)Tc-HYNIC-Lys3-Bombesin obtained with the EDDA/tricine and NA/tricine as coligands].
    Hernández-Cairo A, Perera-Pintado A, Prats-Capote A, Batista-Cuellar JF, Casacó-Santana C.
    Rev Esp Med Nucl Imagen Mol; 2012 Dec 19; 31(2):61-5. PubMed ID: 22305264
    [Abstract] [Full Text] [Related]

  • 20. SPECT/CT Imaging of the Novel HER2-Targeted Peptide Probe 99mTc-HYNIC-H6F in Breast Cancer Mouse Models.
    Li L, Wu Y, Wang Z, Jia B, Hu Z, Dong C, Wang F.
    J Nucl Med; 2017 May 19; 58(5):821-826. PubMed ID: 28104744
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.